SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-147884
Filing Date
2021-12-09
Accepted
2021-12-09 08:01:54
Documents
14
Period of Report
2021-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134930d1_8k.htm   iXBRL 8-K 28986
2 EXHIBIT 99.1 tm2134930d1_ex99-1.htm EX-99.1 6472
6 GRAPHIC tm2134930d1_ex99-1img001.jpg GRAPHIC 11570
  Complete submission text file 0001104659-21-147884.txt   229148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20211208.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20211208_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20211208_pre.xml EX-101.PRE 22715
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2134930d1_8k_htm.xml XML 3615
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 211480312
SIC: 2834 Pharmaceutical Preparations